Our professionals
Partner
Claudio Oksenberg
Areas of expertise
Experience
Claudio focuses his practice on local and cross-border M&A, corporate reorganization, private equity and joint venture transactions. He also advises on regulatory matters involving publicly-held and closely-held companies, as well as capital market transactions and financing. Claudio is admitted to practice law in New York. He previously worked as a foreign associate at Sidley Austin LLP and senior associate at the international law firms Shearman & Sterling and Milbank Tweed Hadley & McCloy LLP.
Education
Bachelor of Laws – Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio);
Postgraduate Course in Corporate Law – Instituto Brasileiro de Mercado de Capitais (Ibmec-RJ);
Master of Laws (LL.M.) – Columbia Law School.
Recognitions
Análise Advocacia 500 – Energy (2019–2020, 2022), M&A (2020), Transport (2022), Rio de Janeiro (2020, 2022);Análise Advocacia 500 – Energy (2019–2020, 2022), M&A (2020), Transport & Logistics (2022), Rio de Janeiro (2020, 2022);
Chambers Brazil – Corporate/Commercial: Rio de Janeiro (2022–2023);
Latin Lawyer 250 – Corporate and M&A, Capital Markets (2020–2024);
The Legal 500 – Corporate/M&A (2017–2019);
Who’s Who Legal Brazil – Capital Markets (2021–2023).
Brazil approves Elanco-Bayer US$7.6 billion animal health deal
Paul, Weiss, Rifkind, Wharton & Garrison LLP in New York and Washington, DC, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados in São Paulo have helped US company Elanco Animal Health obtain Brazilian antitrust clearance for its US$7.6 billion global acquisition of German pharma company Bayer’s animal health business.
Click here and learn more.
Areas of expertise
Stay in touch
Get first-hand access to legal analysis from our specialists in different sectors through texts and podcasts. Stay on top of the main issues that impact your business.
